2025 RiVive Community Feedback Report

https://www.harmreductiontherapeutics.org/wp-content/uploads/2026/04/2025-RiVive-Community-Feedback-Report.pdf#new_tab

Harm Reduction Therapeutics Partners with Capstone Health Alliance to Expand Access to Life-Saving Naloxone Nationwide

by C Tetro | Mar 19, 2026 | News

2024 RiVive Community Feedback Report

by C Tetro | Apr 7, 2025 | News

Harm Reduction Therapeutics Marks International Overdose Awareness Day with Free Donations of RiVive® Life-Saving Over-the-Counter Naloxone Nasal Spray

by Jim Kelly | Sep 3, 2024 | News

Compassionate Overdose Response Summit Highlights and Key Takeaways

by C Tetro | Aug 27, 2024 | News

A2A Alliance Pharmaceuticals and Harm Reduction Therapeutics Announce Strategic Partnership to Expand Access to Life-Saving OTC Naloxone 3mg Nasal Spray (RiVive™) to U.S. Federal Entities and Veterans

by Jim Kelly | Aug 14, 2024 | News